Vascular Cell Adhesion Molecule 1 and E-Selectin as Potential Cardiovascular Risk Biomarkers in Psoriasis

Area of Science:

• Immunodermatology
• Cardiovascular Medicine
• Biomarker Discovery

Background:

• Psoriasis is linked to increased cardiovascular risk, involving endothelial cell activation.
• VCAM-1 and E-selectin are crucial adhesion molecules in inflammatory processes.

Purpose of the Study:

• To review the role of VCAM-1 and E-selectin as biomarkers in psoriasis.
• To explore their connection to cardiovascular risk and treatment response.

Main Methods:

• Literature review of studies on VCAM-1, E-selectin, psoriasis, and cardiovascular disease.
• Analysis of factors influencing biomarker levels and treatment effects.

Main Results:

• VCAM-1 and E-selectin levels correlate with psoriasis severity and endothelial activation.
• Treatments like TNF-α inhibitors and UVB therapy impact these markers.
• Age, metabolic syndrome, and smoking influence biomarker levels.

Conclusions:

• VCAM-1 and E-selectin show potential as biomarkers for inflammation, disease severity, and cardiovascular risk in psoriasis.
• Understanding their role aids in managing psoriasis and related conditions.